Stamatakos Panagiotis Velissarios, Moschotzopoulos Dimitrios, Glykas Ioannis, Fragkoulis Charalampos, Kostakopoulos Nikolaos, Papadopoulos Georgios, Stathouros Georgios, Aristas Odysseas, Dellis Athanasios, Papatsoris Athanasios, Ntoumas Konstantinos
Department of Urology, General Hospital of Athens G.Gennimatas, Athens, Greece.
Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, United Kingdom.
J Frailty Sarcopenia Falls. 2022 Sep 1;7(3):147-150. doi: 10.22540/JFSF-07-147. eCollection 2022 Sep.
This study aims to evaluate the effect of frailty in patients undergoing radical cystectomy (RC) for locally advanced bladder cancer.
In this retrospective, single center study we evaluated 51 patients with pT4 bladder cancer treated with radical cystectomy between 2016-2020. Patient frailty was assessed with the Clinical Frailty Scale (CFS). Furthermore, six separate parameters (early mortality index within 30 days after surgery, death after one year, length of stay, respiratory complications, readmission index, total hospital charges) were also evaluated. The patients were categorized on three groups (Group 1, 2, 3) based on the CFS.
A total of 51 pT4 RC patients were included in the study. Mean age was 75.6 years. Early mortality rate at 30 days after surgery was low all the groups. One year mortality rate was higher in Group 2 (22%) and 3 (69%). The length of stay and the number of patients with respiratory complications were also higher in the frailer groups. 30 days readmission rate was 22% in Group 2 and 38% in Group 3.
Preoperative frailty is associated with worse postoperative results after RC. CFS is an objective tool for patient risk stratification and can predict postoperative complications and mortality.
本研究旨在评估虚弱对局部晚期膀胱癌行根治性膀胱切除术(RC)患者的影响。
在这项回顾性单中心研究中,我们评估了2016年至2020年间接受根治性膀胱切除术的51例pT4期膀胱癌患者。采用临床虚弱量表(CFS)评估患者的虚弱程度。此外,还评估了六个独立参数(术后30天内的早期死亡率、一年后死亡率、住院时间、呼吸并发症、再入院率、总住院费用)。根据CFS将患者分为三组(第1组、第2组、第3组)。
本研究共纳入51例pT4期RC患者。平均年龄为75.6岁。所有组术后30天的早期死亡率均较低。第2组(22%)和第3组(69%)的一年死亡率较高。虚弱程度较高的组住院时间和呼吸并发症患者数量也较多。第2组的30天再入院率为22%,第3组为38%。
术前虚弱与RC术后较差的结果相关。CFS是一种用于患者风险分层的客观工具,可预测术后并发症和死亡率。